Gabelli & CO Investment Advisers, Inc. Surmodics Inc Transaction History
Gabelli & CO Investment Advisers, Inc.
- $584 Million
- Q2 2025
A detailed history of Gabelli & CO Investment Advisers, Inc. transactions in Surmodics Inc stock. As of the latest transaction made, Gabelli & CO Investment Advisers, Inc. holds 203,587 shares of SRDX stock, worth $5.73 Million. This represents 1.04% of its overall portfolio holdings.
Number of Shares
203,587
Previous 195,387
4.2%
Holding current value
$5.73 Million
Previous $5.97 Million
1.39%
% of portfolio
1.04%
Previous 0.99%
Shares
5 transactions
Others Institutions Holding SRDX
# of Institutions
147Shares Held
12.4MCall Options Held
108KPut Options Held
212K-
Black Rock Inc. New York, NY1.17MShares$32.9 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY850KShares$23.9 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA810KShares$22.8 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT789KShares$22.2 Million1.82% of portfolio
-
Morgan Stanley New York, NY656KShares$18.4 Million0.0% of portfolio
About SURMODICS INC
- Ticker SRDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,005,000
- Market Cap $394M
- Description
- Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...